The subject invention relates to viruses that are able to replicate and
thereby kill neoplastic cells with a deficiency in the IFN-mediated
antiviral response, and their use in treating neoplastic disease
including cancer and large tumors. RNA and DNA viruses are useful in this
regard. The invention also relates to methods for the selection, design,
purification and use of such viruses for cancer therapy.